rs74437357
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The ENST00000342358.9(ATP13A5):c.1063C>T(p.Gln355Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0293 in 1,613,820 control chromosomes in the GnomAD database, including 863 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.023 ( 42 hom., cov: 32)
Exomes 𝑓: 0.030 ( 821 hom. )
Consequence
ATP13A5
ENST00000342358.9 stop_gained
ENST00000342358.9 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 9.68
Genes affected
ATP13A5 (HGNC:31789): (ATPase 13A5) This gene encodes a member of the P5 subfamily of P-type transport ATPases. P-type ATPases form a large superfamily of cation and lipid pumps that transport inorganic cations and other substrates across cell membranes. P5 ATPases are localized to membranes of the endoplasmic reticulum (ER) and serve many important functions including transport of cargo proteins to the Golgi, glycosylation and cell wall biosynthesis, control of protein insertion orientation, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) degradation, and sensitivity to unfolded protein response (UPR) activators. The encoded protein is organized into three cytoplasmic domains (A, P, and N) and two membrane-embedded domains (T and S). The N-domain binds ATP and serves as a built-in protein kinase, which phosphorylates the P-domain. The A-domain is an intrinsic protein phosphatase, which dephosphorylates the P-domain once during each catalytic cycle. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 3-193334980-G-A is Benign according to our data. Variant chr3-193334980-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 402400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-193334980-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0231 (3512/152282) while in subpopulation NFE AF= 0.0337 (2291/68016). AF 95% confidence interval is 0.0325. There are 42 homozygotes in gnomad4. There are 1750 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 42 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP13A5 | NM_198505.4 | c.1063C>T | p.Gln355Ter | stop_gained | 10/30 | ENST00000342358.9 | NP_940907.2 | |
ATP13A5 | XM_011512770.3 | c.1063C>T | p.Gln355Ter | stop_gained | 10/27 | XP_011511072.1 | ||
ATP13A5 | XM_047448075.1 | c.19-3669C>T | intron_variant | XP_047304031.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP13A5 | ENST00000342358.9 | c.1063C>T | p.Gln355Ter | stop_gained | 10/30 | 1 | NM_198505.4 | ENSP00000341942 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0231 AC: 3512AN: 152164Hom.: 42 Cov.: 32
GnomAD3 genomes
AF:
AC:
3512
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0220 AC: 5520AN: 251162Hom.: 97 AF XY: 0.0219 AC XY: 2968AN XY: 135732
GnomAD3 exomes
AF:
AC:
5520
AN:
251162
Hom.:
AF XY:
AC XY:
2968
AN XY:
135732
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0299 AC: 43716AN: 1461538Hom.: 821 Cov.: 31 AF XY: 0.0291 AC XY: 21166AN XY: 727052
GnomAD4 exome
AF:
AC:
43716
AN:
1461538
Hom.:
Cov.:
31
AF XY:
AC XY:
21166
AN XY:
727052
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0231 AC: 3512AN: 152282Hom.: 42 Cov.: 32 AF XY: 0.0235 AC XY: 1750AN XY: 74474
GnomAD4 genome
AF:
AC:
3512
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
1750
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
155
ALSPAC
AF:
AC:
139
ESP6500AA
AF:
AC:
24
ESP6500EA
AF:
AC:
256
ExAC
AF:
AC:
2633
Asia WGS
AF:
AC:
18
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC frequency - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at